These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 31598752

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
    Reihl Crnogaj M, Čubelić D, Babić A, Mayer M, Anić B.
    Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
    Song ST, Kim JJ, Lee S, Kim HA, Lee EY, Shin KC, Lee JH, Lee KH, Choi ST, Cha HS, Yoo DH.
    Clin Exp Rheumatol; 2016 Aug; 34(6 Suppl 102):S64-S71. PubMed ID: 27462914
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F, Blanco R, Calvo-Rio V, Narvaez J, Rubio Romero E, Olivé A, Castañeda S, Gallego Flores A, Hernández MV, Mata C, Ros Vilamajo I, Sifuentes Giraldo WA, Caracuel MA, Freire M, Gómez Arango C, Llobet J, Manrique Arija S, Marras C, Moll-Tuduri C, Plasencia-Rodriguez C, Roselló R, Urruticoechea A, Velloso-Feijoo ML, Del Blanco J, González-Vela MC, Rueda-Gotor J, Pina T, Loricera J, González-Gay MA.
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
    Bannai E, Yamashita H, Kaneko S, Ueda Y, Ozaki T, Tsuchiya H, Takahashi Y, Kaneko H, Kano T, Mimori A.
    Mod Rheumatol; 2016 Jun; 26(2):297-301. PubMed ID: 24697199
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serious adverse events in children with juvenile idiopathic arthritis and other rheumatic diseases on tocilizumab - a real-world experience.
    Aeschlimann FA, Dumaine C, Wörner A, Mouy R, Wouters C, Melki I, Uettwiller F, Job-Deslandre C, Quartier P, Bader-Meunier B.
    Semin Arthritis Rheum; 2020 Aug; 50(4):744-748. PubMed ID: 32526594
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adult-onset still's disease and treatment results with tocilizumab.
    Kır S, Özgen M, Zontul S.
    Int J Clin Pract; 2021 Mar; 75(3):e13936. PubMed ID: 33332679
    [Abstract] [Full Text] [Related]

  • 20. Canakinumab for the treatment of adult-onset Still's disease.
    Sfriso P, Bindoli S, Doria A, Feist E, Galozzi P.
    Expert Rev Clin Immunol; 2020 Feb; 16(2):129-138. PubMed ID: 31957508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.